24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy
Clinical trial NCT02243176 · COMPLETED
Trial details
- NCT number
- NCT02243176
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-09-01
- Enrollment
- 689
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.